Passing Blood Clots in Urine: Causes and Workup
All patients passing blood clots in urine (gross hematuria) require urgent urologic evaluation with cystoscopy and imaging, regardless of whether the bleeding is self-limited, because this presentation carries a 30-40% risk of underlying malignancy. 1, 2
Understanding the Clinical Significance
Passing visible blood clots represents gross hematuria, which is fundamentally different from microscopic hematuria in terms of cancer risk and urgency. The presence of blood clots specifically indicates significant bleeding volume and warrants immediate attention.
Key Risk Stratification
The malignancy risk with gross hematuria is dramatically elevated:
This 10-fold difference in cancer probability drives the aggressive workup approach for anyone passing visible blood or clots.
Possible Causes
Blood clots in urine arise from either nephrogenic (kidney) or urogenic (urinary tract) sources 1:
Malignant Causes (Must Be Excluded First)
- Bladder cancer
- Kidney cancer
- Upper urinary tract (ureter/renal pelvis) cancer
- Prostate cancer
Benign Causes
Urogenic (more common):
- Kidney stones (urolithiasis) - especially when accompanied by flank pain
- Urinary tract infection
- Benign prostatic hypertrophy (in men)
- Urethral hemangioma (rare but causes postejaculation/posterection bleeding) 3
Nephrogenic:
- Renal parenchymal disease (glomerulonephritis, glomerulonephropathy)
- Acute kidney injury
- Acute tubular necrosis
High-Risk Features Requiring Immediate Evaluation
Refer urgently if ANY of these factors are present 1:
- Male gender
- Age >35 years
- Smoking history
- Occupational chemical exposure
- Analgesic abuse
- History of urologic disease
- Irritative voiding symptoms
- History of pelvic irradiation
- Chronic urinary tract infections
- Exposure to chemotherapy (especially cyclophosphamide)
- Chronic indwelling catheter
Recommended Workup Algorithm
Step 1: Initial Assessment (Before Imaging)
- Thorough history focusing on risk factors above
- Physical examination (pelvic exam in women, rectal exam in men)
- Urinalysis with microscopy
- Urine culture (if infection suspected, obtain BEFORE antibiotics)
- Serologic testing
- Do NOT obtain urinary cytology - it lacks sensitivity and will not change management 2
Step 2: Urgent Urologic Referral
Refer immediately for 2:
- Cystoscopy (bladder endoscopy)
- Upper tract imaging
Step 3: Imaging Protocol
CT Urography (CTU) is the preferred imaging modality 1:
- Includes unenhanced images (to detect stones)
- IV contrast-enhanced images with nephrographic phase
- Excretory phase (at least 5 minutes post-contrast)
- Thin-slice acquisition with 3D reconstruction
Alternative: MR Urography if CT contraindicated 1
Step 4: Cystoscopy
Required in all cases of gross hematuria 1, 2 to directly visualize:
- Bladder mucosa for tumors
- Urethra for lesions
- Prostatic urethra in men
Critical Clinical Pitfalls to Avoid
Pitfall #1: Attributing Hematuria to Anticoagulation Alone
Never dismiss gross hematuria as simply due to anticoagulants or antiplatelet therapy 2, 4. While these medications increase bleeding risk, they do not cause hematuria without an underlying anatomic lesion. The full urologic workup must proceed regardless of anticoagulation status 1, 2.
Rivaroxaban and warfarin carry the highest risk for hematuria complications, but this does not eliminate the need for cancer evaluation 5.
Pitfall #2: Waiting for Recurrence
Even a single self-limited episode of gross hematuria requires full evaluation 2. Do not adopt a "wait and see" approach - the cancer risk remains substantial even if bleeding stops spontaneously.
Pitfall #3: Assuming Infection is the Cause
If urinary tract infection is suspected:
- Obtain urine culture BEFORE starting antibiotics 1
- If infection is confirmed and treated, still proceed with full urologic evaluation if patient has risk factors
- Infection may coexist with malignancy
Pitfall #4: Overlooking Timing Clues
Ask specifically about bleeding timing 3:
- Postejaculation or posterection bleeding suggests urethral hemangioma
- Bleeding with flank pain suggests stones
- Painless bleeding has stronger cancer association
Pitfall #5: Incomplete Workup in Younger Patients
While age >35 increases cancer risk, younger patients with gross hematuria still require evaluation, especially if other risk factors are present 1.
Special Considerations
Renal Parenchymal Disease
If glomerulonephritis or other kidney disease is suspected (proteinuria, RBC casts, dysmorphic RBCs, hypertension, renal insufficiency):
- Concurrent nephrology evaluation is appropriate
- However, this does NOT preclude urologic evaluation 1
- Both evaluations should proceed in parallel
Benign Causes That May Defer Workup
Only in patients WITHOUT risk factors, consider deferring full workup if clear benign cause identified 1:
- Recent vigorous exercise
- Menstruation (in women)
- Recent urologic procedure
- Documented trauma
Even in these cases, if bleeding recurs or risk factors are present, proceed with full evaluation.
Documentation and Follow-up
Ensure documentation includes:
- Exact description of blood/clots (color, size, frequency)
- Associated symptoms (pain, dysuria, frequency)
- All risk factors present or absent
- Anticoagulation/antiplatelet medications and dosing
- Timing relationship to activities (exercise, intercourse, voiding)
The primary goal is excluding malignancy through comprehensive urologic evaluation with both cystoscopy and cross-sectional imaging - this approach prioritizes mortality reduction through early cancer detection.